Who owns the RELESIUM trademark?

The RELESIUM trademark is owned by PanTheryx, Inc..

What class is the RELESIUM trademark registered in?

The RELESIUM trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RELESIUM?

The USPTO serial number for RELESIUM is 98722747.

What is the registration number for RELESIUM?

RELESIUM is registered under USPTO registration number 8404059.

Sealvo

Home Search: RELESIUMRELESIUM #98722747

Back

Updated Oct 5, 2026·30 searches this week

View on USPTO TSDR Find similar marks

REL

USPTO Trademark Record

REGISTERED

RELESIUM

SN 98722747·Reg 8404059·Filed Aug 28, 2024

Owner PanTheryx, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RELESIUM (Serial No. 98722747), Registration No. 8404059, is a registered US trademark filed on Aug 28, 2024 by PanTheryx, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 18, 2032

Mark Intelligence

RELESIUM (Reg. #8404059) is a registered US trademark that has been protecting its owner, PanTheryx, Inc., since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 28, 2024

SERIAL

98722747

REG#

8404059

REGISTERED

Aug 18, 2026

Filing Information

StatusREGISTERED

Filing DateAug 28, 2024

Serial Number98722747

Registration No.8404059

Registration DateAug 18, 2026

Status DateAug 18, 2026

Published for OppositionApr 01, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Feb 18, 2025

First use in commerce: Feb 18, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Aug 18, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 18, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 30, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 30, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jul 27, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jul 27, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

SU - NON-FINAL ACTION - WRITTEN

Apr 28, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Apr 28, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 28, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 17, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 15, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Nov 12, 2025

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Nov 12, 2025

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 27, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 01, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 01, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 26, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 05, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 04, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Aug 28, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 28, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by PanTheryx, Inc.

Additional USPTO filings from the same owner.

SOO

SOOTHING RELIEF DIARESQ DIARRHEA RELIEF

87331634

PanTheryx, Inc.

REGISTERED

RAP

RAPID RECOVERY DIARESQ DIARRHEA RELIEF

87313052

PanTheryx, Inc.

REGISTERED

DIA

DIARESQ

85625482

PanTheryx, Inc.

REGISTERED

LIF

LIFE'S FIRST NATURALS

88796869

PanTheryx, Inc.

REGISTERED

Other Marks by Michael A. Geller

Additional USPTO filings handled by the same attorney of record.

ROY

ROYAL FERN DR. TIMM GOLUEKE

79268721

REGISTERED

STA

STAX ENGINEERING

99361108

REGISTERED

EHO

EHOUSE

99401890

REGISTERED

STA

STAX

99360992

REGISTERED

RELESIUM

Run a conflict check

Other Marks by PanTheryx, Inc.

Other Marks by Michael A. Geller

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company